title: Adjuvant antiviral therapy for recurrent respiratory papillomatosis.
abstract: BACKGROUND
  Recurrent respiratory papillomatosis is a condition characterised by benign papillomatous (wart-like) growths in the upper airway. It can affect both adults and children causing airway-obstruction and voice change. Treatment usually involves repeated surgical debulking of the papillomata, and several agents have been proposed as adjuvants to surgical debulking. These include antivirals, administered systemically or injected into the lesions.
  
  
  OBJECTIVE
  To assess the effectiveness of antiviral agents as adjuvant therapy in the management of recurrent respiratory papillomatosis in children and adults.
  
  
  METHODS
  We searched the Cochrane Central Register of Controlled Trials (The Cochrane Library, Issue 3, 2004), MEDLINE (January 1966 to November 2004), and EMBASE (January 1985 to November 2004) in December 2004. We checked reference lists of articles, contacted pharmaceutical companies and contacted leading experts in the field for further studies.
  
  
  METHODS
  All randomised controlled trials.
  
  
  METHODS
  One hundred references were identified from the searches. Twenty-five were appropriate for retrieval and assessed for eligibility by the authors. None met the inclusion criteria.
  
  
  RESULTS
  No controlled trials were identified.
  
  
  CONCLUSIONS
  There was insufficient evidence from controlled trials on which to base reliable conclusions about the effectiveness of antiviral agents as adjuvant therapy in the management of recurrent respiratory papillomatosis. Further research is required before any specific antiviral adjuvant therapy can be recommended.
authors.affiliation: Royal United Hospital, ENT Department, Bath, UK BA1 3NG. neil@chadhanet.com
authors.forename: N K
authors.initials: NK
authors.lastname: Chadha
authors.forename: A L
authors.initials: AL
authors.lastname: James
mesh_terms: D000328:Adult; D000402:Airway Obstruction / Q000188:drug therapy / Q000821:virology; D000998:Antiviral Agents / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D002648:Child; D006801:Humans; D010212:Papilloma / Q000188:drug therapy*; D012008:Recurrence; D012142:Respiratory Tract Neoplasms / Q000188:drug therapy* / Q000821:virology
chemical_list: D000998:Antiviral Agents